戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 al transmission is estimated below 4% of the cumulative incidence.
2 incidence ratios, excess absolute risks, and cumulative incidences.
3 ients relative to Ki/SPK recipients: 10-year cumulative incidences 0.36 (95% confident interval 0.33-
4 a substantially higher risk for HCC (10-year cumulative incidence, 13.60%) than patients with a low m
5 iated with an increased rate of TMN (10-year cumulative incidence, 14.1% v 4.3% for those with and wi
6 iovascular causes was more frequent (10-year cumulative incidence, 14.6% [95% CI, 13.7%-15.4%] for br
7 spital following self-harm during childhood (cumulative incidence 21.4% [95% CI 19.8-23.1]).
8 erpersonal violence injury during childhood (cumulative incidence 25.0% [95% CI 21.2-28.9]).
9 , 1.3 to 1.6) and respiratory complications (cumulative incidence, 27% v 20%; HR, 1.4; 95% CI, 1.2 to
10 alizations or death with infections (10-year cumulative incidence, 31% v 22%; HR, 1.4; 95% CI, 1.3 to
11 thout NNAs, 64 (29%) developed an inhibitor (cumulative incidence, 34.0%; 95% CI, 27.1%-40.9%).
12 s with a low metabolic risk profile (10-year cumulative incidence, 4.83%; adjusted-hazard ratio, 2.32
13 r advanced stage at first diagnosis (15-year cumulative incidence, 5.3% v 3.9% and 3.9%, respectively
14                                              Cumulative incidence after a 5-year period was high for
15                  Main Outcomes and Measures: Cumulative incidence and hazard ratios (HRs) for SMN and
16                   Age-specific incidence and cumulative incidence and median age at the detection of
17 de the late effects of cancer therapy) using cumulative incidence and piecewise exponential models to
18                                          The cumulative incidence and prevalence of endocrine abnorma
19                       To estimate the 6-year cumulative incidence and progression of AMD in older adu
20 d conventional vaccines compare, in terms of cumulative incidence and rates of antigenic evolution of
21                             To determine the cumulative incidence and the prognostic factors of ileor
22           We estimated dementia and AD risk (cumulative incidence) and studied factors associated wit
23                                              Cumulative incidences as of age 70 were estimated accoun
24                                              Cumulative incidences at 10, 15, and 20 years rose linea
25                                          The cumulative incidences at age 50 years among CCSS low-ris
26 erall morbidity compared with currently used cumulative incidence based analytic methodologies, and w
27  and 10-year overall survival (OS) and crude cumulative incidence (CCI) of local recurrence (LR) and
28 y variables that independently decreased the cumulative incidence (CI) of chronic graft-versus-host d
29                  Subsequent neoplasm 15-year cumulative incidence, cumulative burden, and standardize
30                                              Cumulative incidence curves and prevalence estimates qua
31                       We computed stratified cumulative incidence curves by age (60-64, 65-69, 70-75
32 ditions is more appropriately represented by cumulative incidence data.
33 io 1.91 [95% CI 1.63-2.25]; adjusted 10-year cumulative incidence difference 14.1 [95% CI 10.1-18.0]
34                                          The cumulative incidence estimates of grades 2-4 and 3-4 acu
35                              At 2 years, the cumulative incidence estimates of nonrelapse mortality a
36                 At 6, 18, and 30 months, the cumulative incidence estimates of SCD were 0.79%, 1.65%,
37 g Kaplan-Meier for overall survival (OS) and cumulative incidence for biochemical recurrence (BcR), d
38                                The estimated cumulative incidence for CDA in the Denver general popul
39                                    Five-year cumulative incidence for LR was 39% and for DR was 24%.
40 = 0.5 versus > 0.5 ng/mL, 5-year and 10-year cumulative incidences for BcR were 42% versus 56% and 60
41  a 22q11.2 deletion or duplication, IRR, and cumulative incidences for psychiatric diagnoses (Interna
42  hazards for the possible outcomes, then the cumulative incidence function for a given candidate usin
43                                              Cumulative Incidence Function was used to calculate AIDS
44 cidence of outcomes, analysts should use the cumulative incidence function, rather than the complemen
45  or modeling the effect of covariates on the cumulative incidence function.
46                                      We used cumulative incidence functions to compare temporal chang
47                                              Cumulative incidence functions were used for GSS analysi
48                                              Cumulative incidence functions were used to describe the
49                                              Cumulative incidence functions were used to estimate the
50 ue to clinical worsening was estimated using cumulative incidence functions, where transplantation wa
51 ning, unbiased estimates are available using cumulative incidence if the screen arm stops screening a
52                              To estimate the cumulative incidence in the Denver general population, o
53  We used Kaplan-Meier methods to analyse the cumulative incidence, incidence proportion, and incidenc
54                                              Cumulative incidence increased markedly after the age of
55 creen trials and population settings, excess cumulative incidence is persistently biased.
56                                  The 10-year cumulative incidence metastases rates were 5.5%, 15.0%,
57  12 months, and at 12 months, as well as the cumulative incidence occurring between 3 and 12 months.
58 elanoma experienced local recurrence, with a cumulative incidence of 11%.
59 udden cardiac death during follow-up, with a cumulative incidence of 22% at 1 year and 26% at 5 years
60 sidual urinary incontinence, equivalent to a cumulative incidence of 23.1 per 1000 person-years (14.0
61 0 days following induction, for an estimated cumulative incidence of 3.7% (95% confidence interval [C
62 netic risk, whereas high-risk patients had a cumulative incidence of 31%.
63 osed in 23,980 individuals, translating to a cumulative incidence of 32%.
64 ts subsequently developed an inhibitor for a cumulative incidence of 45.4% (95% confidence interval [
65  [CI], 1.2-4.2) per 1000 infant-months and a cumulative incidence of 5.2 cases (95% CI, 2.6-9.0) per
66 urrent fistulas occurred, corresponding to a cumulative incidence of 71 per 1000 person-years (95% CI
67 ccurred in 94 and 49 patients, with a 2-year cumulative incidence of 79.2% (95% confidence interval [
68                                       Annual cumulative incidence of 9-valent vaccine types was 19% a
69  a median follow-up period of 6.3 years, the cumulative incidence of a subsequent diagnosis with celi
70                                          The cumulative incidence of a subsequent meningioma by age 4
71                                          The cumulative incidence of ACE increased by 16.5% per Gy (9
72                    The primary end point was cumulative incidence of ACEs within 9 years of follow-up
73                                          The cumulative incidence of acute grade III-IV GVHD was 12%.
74                                          The cumulative incidence of admission to a SNF ranged from 1
75 Gray model was used to measure the burden of cumulative incidence of AIDS-related mortality and stren
76                  We also assessed the 3-year cumulative incidence of all fracture locations (excludin
77                                          The cumulative incidence of all inhibitors was 26.8% (95% co
78             After 35 years of follow-up, the cumulative incidence of all-cause dementia in the MI coh
79              Through 2 years, the unadjusted cumulative incidence of all-cause mortality (16.0% versu
80                                              Cumulative incidence of all-cause mortality at 2 years i
81 Cox proportional hazards models, we compared cumulative incidence of all-cause mortality, device-rela
82                                              Cumulative incidence of AMD increased with age (>/=80 ye
83 oncentrations of 8-10 mug fHb/g had a higher cumulative incidence of AN (33%) than participants with
84 , those born between January and April), the cumulative incidence of an ADHD diagnosis was greatest f
85                             Groups with high cumulative incidence of anal cancer may benefit from scr
86 to assess temporal trends, and estimated the cumulative incidence of anal cancer to measure absolute
87  not find any significant differences at the cumulative incidence of anti-TG2A positivity (hazard rat
88                                          The cumulative incidence of anxiety and depression during th
89                                              Cumulative incidence of any first (35.5% versus 69.0%; P
90 .5% (CI, 2.8% to 8.1%) in the 5- and 10-year cumulative incidence of any fracture, respectively.
91                                              Cumulative incidence of any neuroendocrine deficit at 5
92                                          The cumulative incidence of any type of CD at 40 years of ag
93                                          The cumulative incidence of AR at 1 year was 58% and 21% amo
94                                          The cumulative incidence of AR was lower in eHF-C (risk rati
95                                  The 6-month cumulative incidence of arterial thromboembolism was 4.7
96  who received mechanical valves had a higher cumulative incidence of bleeding and, in some age groups
97                  By the age of 45 years, the cumulative incidence of breast cancer in sarcoma and leu
98                                  The 30-year cumulative incidence of breast cancer in women diagnosed
99 over a median follow-up of 96 months, with a cumulative incidence of breast cancer mortality at 10 ye
100                                          The cumulative incidence of cancer estimated up to 64 years
101                                              Cumulative incidence of cardiac events (CE) and left ven
102                                   The 2-year cumulative incidence of cardiac events was 0.28 (95% CI,
103                          However, the 5-year cumulative incidence of CBC remained significantly highe
104 isk factors for celiac disease, we found the cumulative incidence of CDA and celiac disease to be hig
105                       For each genotype, the cumulative incidence of CDA and celiac disease were dete
106                                          The cumulative incidence of CE at 6 years was slightly highe
107                     We aimed to estimate the cumulative incidence of celiac disease in adolescents bo
108                                              Cumulative incidence of chronic GVHD at 1 year was signi
109                                          The cumulative incidence of chronic GVHD was 29%; relapse, n
110   After a median follow-up of 24 months, the cumulative incidence of chronic GVHD was 32.2% (95% conf
111 multivariable-adjusted differences in 5-year cumulative incidence of CKD in underweight, overweight,
112  new vertebral fracture at 24 months and the cumulative incidence of clinical fracture (nonvertebral
113                                          The cumulative incidence of clinically relevant bleeding (ma
114                                    Five-year cumulative incidence of complications such as graft reje
115 aplan-Meier method was used to calculate the cumulative incidence of corneal edema.
116                             In addition, the cumulative incidence of CVD events in the highest quarti
117                                          The cumulative incidence of death after a bleeding event amo
118                                          The cumulative incidence of death after an ischemic event am
119 re comorbidities in recent years, the 3-year cumulative incidence of death or major cardiovascular ev
120                                          The cumulative incidence of death was lower for patients wit
121 ivariable modeling were used to estimate the cumulative incidence of death, transplant, and echocardi
122                  The primary outcome was the cumulative incidence of delirium, assessed bid using the
123                                              Cumulative incidence of developing new neuroendocrine dy
124                                         When cumulative incidence of diabetes was analysed by quartil
125 sceptibility for type 1 diabetes reduced the cumulative incidence of diabetes-associated autoantibodi
126                                              Cumulative incidence of disengagement from care was esti
127 s 72.9% (95% CI 70.2-75.7) and 10-year crude cumulative incidence of distant metastases was 25.0% (95
128  approved dose of 1.3 mg/m(2), the estimated cumulative incidence of DLT was > 50%, and the estimated
129                                          The cumulative incidence of dnDSA was 47% at a median of 86
130 ncidence of DLT was > 50%, and the estimated cumulative incidence of dose reduction or treatment disc
131                                    Five-year cumulative incidence of DSD was 31%, and factors indepen
132 ough evidence of an event, we determined the cumulative incidence of each event.
133                   We examined the unadjusted cumulative incidence of each outcome studied from hospit
134  death at 10 years after diagnosis, when the cumulative incidence of each was 5%.
135  The 6-year weighted (for loss to follow-up) cumulative incidence of early AMD was 164.2 per 1000 per
136                                 At 10 years, cumulative incidence of EBRT was 5.9% (SE +/- 3), and ev
137                          Primary outcome was cumulative incidence of eczema by 12 months in infants r
138                      Secondary outcomes were cumulative incidence of eczema by 12 or 18 months in all
139                                          The cumulative incidence of eczema was reduced in pHF-W (RR
140                                          The cumulative incidence of epilepsy was 24.7% (95% CI 16.2-
141                                          The cumulative incidence of epilepsy was lower in patients w
142               Prognostic analyses focused on cumulative incidence of failure (including primary refra
143                             We described the cumulative incidence of first disengagement (>180 days n
144                      Conclusion The 24-month cumulative incidence of grade >/= 3 cardiac events excee
145                                          The cumulative incidence of grade 2 to 4 acute GVHD at day 1
146                                          The cumulative incidence of grade 3-4 hearing loss at 3 year
147                                              Cumulative incidence of grade II to IV acute GvHD was 22
148                                          The cumulative incidence of grade III to IV acute graft-vers
149                                  The 100-day cumulative incidence of grade III-IV acute GVHD on univa
150 ratio, 5.06; 95% CI, 2.23-11.47) and 10-year cumulative incidence of HCC (25.0% in smokers with 3 or
151  risk factors had significant differences in cumulative incidence of HCC and liver-related death.
152           In a post hoc analysis, the 2-year cumulative incidence of hematological relapse was 33.5%
153 7 to 54.3) with recombinant factor VIII; the cumulative incidence of high-titer inhibitors was 18.6%
154 skull, toes, and fingers) and falls, 10-year cumulative incidence of hip fracture alone, and nonverte
155                                  The 10-year cumulative incidence of hip fracture in all recipients w
156 ogic transformation at diagnosis, the 5-year cumulative incidence of histologic transformation was 2%
157 odel with delayed entry was used to estimate cumulative incidence of histologically proven cSCC and t
158 rtion of ICD recipients enrolled in hospice, cumulative incidence of hospice admission, and factors a
159                                          The cumulative incidence of hospitalizations was 65.4%, rang
160                                 The 12-month cumulative incidence of HR-HPV detection was 25.4% (95%
161                                  The 20-year cumulative incidence of IBTR in 1616 patients (160 event
162                                          The cumulative incidence of incisional hernias at 2-year fol
163                                              Cumulative incidence of infection at 1 year post implant
164                       Results RT reduced the cumulative incidence of ipsilateral breast tumor recurre
165                                  The 6-month cumulative incidence of ischemic stroke was 3.0% (95% CI
166  to 18 months, hazard ratio [HR] = 2.69) and cumulative incidence of leukemic evolution (from 0% to 4
167 e survival (EFS), overall survival (OS), and cumulative incidence of local progression (CILP).
168 east irradiation had a local recurrence; the cumulative incidence of local recurrence was 1.44% (95%
169                                          The cumulative incidence of LTP at 12-month follow-up was 22
170                                 The two-year cumulative incidence of lymphedema was as follows: 4.08%
171 n-treated group (HR 0.97, 95% CI 0.77-1.22); cumulative incidence of major bleeding was 0.3% (95% CI
172                 At 5 years of follow-up, the cumulative incidence of mesh-related complications was 5
173                                          The cumulative incidence of metastatic prostate cancer at 12
174                                              Cumulative incidence of MI was assessed over 3 months af
175  648 randomly assigned patients, the monthly cumulative incidence of MI was lower with continued thie
176                                   The 5-year cumulative incidence of mortality was 11.65% under obser
177 0, 4.3 years), the overall 1-year and 5-year cumulative incidence of mortality was 13.5% (95% confide
178                                  The 6-month cumulative incidence of myocardial infarction was 2.0% (
179                                          The cumulative incidence of National Institutes of Health (N
180        Univariate survival regression on the cumulative incidence of NC identified period of transpla
181                               The unadjusted cumulative incidence of NEC at week 8 among RBC transfus
182                                          The cumulative incidence of new blindness and sight impairme
183              The primary end points were the cumulative incidence of new vertebral fracture at 24 mon
184                                          The cumulative incidence of nodal recurrences at 10 years wa
185                                              Cumulative incidence of nonrelapse mortality at 1 year w
186                      Four patients died, the cumulative incidence of nonrelapse mortality being 5%, w
187 ear overall survival was 83%, and the 1-year cumulative incidence of nonrelapse mortality was 14%.
188                                          The cumulative incidence of nonrelapse mortality was 16% by
189               Recipients had a higher 3-year cumulative incidence of nonvertebral fracture (1.6%; 95%
190 ged 50 years or older had the highest 3-year cumulative incidence of nonvertebral fracture (3.1%; 95%
191 databases to estimate the 3-, 5- and 10-year cumulative incidence of nonvertebral fracture (proximal
192              Eligible studies describing the cumulative incidence of OIs and proportion on ART from 1
193                             To determine the cumulative incidence of optic disc hemorrhage (ODH) befo
194                      The primary outcome was cumulative incidence of ototoxicity at 3 years, graded w
195 esized that the relationship between sex and cumulative incidence of PAD differed according to age.
196                                 Although the cumulative incidence of partial remission was lower in t
197                                          The cumulative incidence of PAS per 100000 pregnant/postpart
198        During 12 months of surveillance, the cumulative incidence of patients undergoing 3 or more CA
199 -2009 vs 91% in 2010-2012 (P = .95), and the cumulative incidence of patients undergoing more than 1
200                                          The cumulative incidence of POAG in eyes with ODH was 25.6%
201                                          The cumulative incidence of pre-engraftment GNB was 17.3% in
202       In 305 women at risk of pregnancy, the cumulative incidence of pregnancy was 106.0 per 1000 per
203                     Measurements: Weekly and cumulative incidence of prenatal infections and microcep
204 ns to delay pregnancy by 9 to 24 months, the cumulative incidence of prenatal Zika virus infections i
205 n follow-up time of 3.4 years, the estimated cumulative incidence of progression at 4 years is 19% (9
206 veloped late AMD at follow-up, with a 6-year cumulative incidence of progression from early to late A
207 , or decrease in category and to compare the cumulative incidence of progression in category.
208                                          The cumulative incidence of progression to a malignant categ
209                                          The cumulative incidence of progression to at least category
210                                   The 5-year cumulative incidence of PTM in patients with and without
211                             We estimated the cumulative incidence of reaching a particular cascade st
212                                          The cumulative incidence of receiving a second shock was 14.
213                                              Cumulative incidence of recurrences was estimated with c
214                                          The cumulative incidence of rejection episodes was significa
215                                   The 5-year cumulative incidence of relapse (+/- standard error) was
216                                    Five-year cumulative incidence of relapse (CIR) and disease-free s
217 e survival (EFS), overall survival (OS), and cumulative incidence of relapse (CIR).
218 m peripheral blood-MRD (PB-MRD) had a higher cumulative incidence of relapse (subhazard ratio [SHR],
219    Gain in RFS could be related to the lower cumulative incidence of relapse observed in the CLARA ar
220  MUD, respectively, and corresponding 2-year cumulative incidence of relapse or progression was 39%,
221 te 87%, 5-year survival rate 92%, and 5-year cumulative incidence of relapse rate 8%) compared with p
222 urvival rate was 99% (SE 1%), and the 5-year cumulative incidence of relapse rate was 6% (SE 2%).
223                                          The cumulative incidence of relapse was 7.5% at 5 years.
224 -up of 40.6 months, the event-free survival, cumulative incidence of relapse, and overall survival at
225  5%, whereas 19 relapsed, resulting in a 24% cumulative incidence of relapse.
226  +/- 3% vs 89% +/- 4%; Plog-rank = .71), and cumulative incidence of relapse/nonresponse (CIR/NR; 6%
227                                              Cumulative incidence of relapse/progression at 3 years w
228                              At 2 years, the cumulative incidence of repeated overdose was 17% (95% C
229 othesized that BCG at birth would reduce the cumulative incidence of RW during the first year of life
230                                          The cumulative incidence of SCD and cardiovascular death was
231                                   The 5-year cumulative incidence of SCD was 8.5%.
232 calculated standardized incidence ratios and cumulative incidence of second cancer in HL survivors an
233                                          The cumulative incidence of second primary malignancies at 6
234 verse events and stroke was <1%, whereas the cumulative incidence of serious adverse events and muscu
235 nic health conditions, such that the 15-year cumulative incidence of severe or life-threatening chron
236 cant differences in either the proportion or cumulative incidence of side-effects 5 years after treat
237                                          The cumulative incidence of skin-only, grade 1-2 acute GVHD
238                                  The 20-year cumulative incidence of SMN with death as a competing ri
239                  Main Outcomes and Measures: Cumulative incidence of speech/language, scholastic, or
240 l, population-based cohort study, we found a cumulative incidence of strabismus consistent with those
241                                              Cumulative incidence of subsequent all-cause mortality w
242                                          The cumulative incidence of sudden death at 90 days after ra
243                                          The cumulative incidence of surgery at 30 days, 6 months, 1
244                         At age 50 years, the cumulative incidence of survivors experiencing at least
245       Ultimately, they had a very low 5-year cumulative incidence of T1D.
246                                          The cumulative incidence of the primary outcome was 3.08% (9
247                  In the external cohort, the cumulative incidence of therapy-related myeloid neoplasm
248                                          The cumulative incidence of therapy-related myeloid neoplasm
249                   The absolute difference in cumulative incidence of type 2 DM between the lowest and
250                                              Cumulative incidence of VF was estimated and competing r
251                        During follow-up, the cumulative incidence of violence-related arrest for pati
252 s (median follow-up 6 months), a significant cumulative incidence of weight loss between baseline and
253 iate sensitivity analyses indicated that the cumulative incidence of ZIKV infection and risk of micro
254                    We aimed to determine the cumulative incidence of/risk factors for long-term cance
255  survivors had significantly greater 10-year cumulative incidences of all major organ-system outcomes
256                                          The cumulative incidences of breast cancer at age 55 were 3.
257                 The 1-, 5-, 10-, and 20-year cumulative incidences of cancer were 2.1%, 8.6%, 18.7%,
258 th UDCA, OCA+UDCA could decrease the 15-year cumulative incidences of decompensated cirrhosis from 12
259 s who did not receive ADT, had higher 3-year cumulative incidences of depression (7.1% v 5.2%, respec
260                        To compare the 1-year cumulative incidences of events when events were identif
261                                              Cumulative incidences of graft failure, cytomegalovirus,
262                                          The cumulative incidences of initial grades I-IV, II-IV, and
263                              Five-year crude cumulative incidences of local recurrence and distant me
264                                              Cumulative incidences of molecular relapse by 12 and 48
265                                          The cumulative incidences of postoperative complications wer
266 analogues indefinitely yielded 1- and 3-year cumulative incidences of recurrence, defined by positive
267                                   The 2-year cumulative incidences of relapse/progression among patie
268                The primary outcomes were the cumulative incidences of symptomatic venous thromboembol
269 dence rate ratios (IRRs; relative risks) and cumulative incidence percentage values (absolute risks)
270 0.4%, whereas the highest stress group had a cumulative incidence proportion of approximately 1.2%.
271                The lowest stress group had a cumulative incidence proportion of either receiving trip
272                                          The cumulative incidence rate of a second primary malignancy
273                                              Cumulative incidence rate of first alcohol relapse was 2
274                                   The 8-year cumulative incidence rate of secondary malignancies was
275                                              Cumulative incidence rate/100,000 population (CIR) of ne
276                                          The cumulative incidence rates of all-cause death were not s
277                              By 3 years, the cumulative incidence rates of mortality and readmission
278 recurrent MI modeled as competing risks, the cumulative incidence rates of post-MI HF among patients
279 e versus placebo or observation, whereas the cumulative incidence rates of progression, death, or dea
280                                          The cumulative incidence rates of sudden death were assessed
281                                              Cumulative incidence rates were calculated using competi
282                                Outcomes were cumulative incidence (risk) and risk ratio of new-onset
283                                 We estimated cumulative incidence, risk factors, and mortality from d
284 xial length and spherical equivalent, with a cumulative incidence (SE) of visual impairment of 3.8% (
285       Triggered campaigns reduce the highest cumulative incidence seen in simulations by up to 80%.
286 uartile range, 6 to 24 months), and 24-month cumulative incidence was 11% (95% CI, 5% to 16%).
287 nd had follow-up images gradable for GA, the cumulative incidence was 12% at 1 year, 17% at 2 years,
288 d 273 composite CVD events occurred, and the cumulative incidence was 18.4%, 16.5%, 20.6%, and 29.8%
289 vascular death, and repeat revascularization cumulative incidence was 2.3% (95% confidence interval [
290                                Five-year AML cumulative incidence was 20.3%, 20.3%, and 11.3% for tho
291            Among APOE-e4/e4 individuals, 5-y cumulative incidence was as follows: in the 60-64-y age
292                                              Cumulative incidence was calculated with death considere
293 mately 20% for high-risk groups ( P < .001); cumulative incidence was only 1% for siblings ( P < .001
294                                          The cumulative incidence was similar in nonusers compared wi
295                                     Overall, cumulative incidence was uniformly higher in NACC than i
296                                By use of the cumulative incidence, we estimated 5- and 10-year risks
297 83.2), and 5-year estimates of local relapse cumulative incidence were 1.1% (95% CI 0.5-2.3) of patie
298                Kaplan-Meier estimates of the cumulative incidence were generated.
299 ators of 22q11.2 deletion or duplication and cumulative incidences were estimated using a nested case
300             Relative to non-black women, the cumulative incidences were increased in black women (68%

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top